Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Jul;100(3):626–630. doi: 10.1111/j.1476-5381.1990.tb15857.x

The role of adenosine in the hyperaemic response of the hepatic artery to portal vein occlusion (the 'buffer response').

R T Mathie 1, B Alexander 1
PMCID: PMC1917785  PMID: 1697200

Abstract

1. Adenosine has been shown to be responsible for the hyperaemic response of the hepatic artery to portal vein occlusion (the hepatic arterial 'buffer response'). 2. The effect of adenosine receptor blockade and of adenosine uptake inhibition on the hepatic arterial response to portal vein occlusion was investigated in three groups of anaesthetized dogs. 3. Venous return and arterial blood pressure were maintained during periods of portal occlusion by establishing a side-to-side portacaval shunt. Hepatic artery and portal vein blood flows were measured with electromagnetic flowmeters. 4. Hepatic arterial infusions of 8-phenyltheophylline (500 micrograms kg-1 and 3-isobutyl-1-methylxanthine min-1) and 3-isobutyl-1-methylxanthine (75 micrograms kg-1 min-1), doses sufficient to block the vasodilator response of the hepatic artery to exogenously applied adenosine, reduced the magnitude of the 'buffer response' by 50% and 75%, respectively. 5. Intravenous infusion of dipyridamole (100 micrograms kg-1 min-1), a dose sufficient to potentiate the vasodilator response of the hepatic artery to exogenously applied adenosine, had little effect on the 'buffer response'. 6. It is concluded that adenosine is an important, but not the sole, agent responsible for the hepatic arterial 'buffer response'.

Full text

PDF
626

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander B., Blumgart L. H., Mathie R. T. The effect of propranolol on the hyperaemic response of the hepatic artery to portal venous occlusion in the dog. Br J Pharmacol. 1989 Feb;96(2):356–362. doi: 10.1111/j.1476-5381.1989.tb11825.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERNE R. M. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol. 1963 Feb;204:317–322. doi: 10.1152/ajplegacy.1963.204.2.317. [DOI] [PubMed] [Google Scholar]
  3. Bardenheuer H., Schrader J. Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol. 1986 Feb;250(2 Pt 2):H173–H180. doi: 10.1152/ajpheart.1986.250.2.H173. [DOI] [PubMed] [Google Scholar]
  4. Berne R. M., Knabb R. M., Ely S. W., Rubio R. Adenosine in the local regulation of blood flow: a brief overview. Fed Proc. 1983 Dec;42(15):3136–3142. [PubMed] [Google Scholar]
  5. Ezzat W. R., Lautt W. W. Hepatic arterial pressure-flow autoregulation is adenosine mediated. Am J Physiol. 1987 Apr;252(4 Pt 2):H836–H845. doi: 10.1152/ajpheart.1987.252.4.H836. [DOI] [PubMed] [Google Scholar]
  6. Granger H. J., Norris C. P. Role of adenosine in local control of intestinal circulation in the dog. Circ Res. 1980 Jun;46(6):764–770. doi: 10.1161/01.res.46.6.764. [DOI] [PubMed] [Google Scholar]
  7. Kock N. G., Hahnloser P., Roding B., Schenk W. G., Jr Interaction between portal venous and hepatic arterial blood flow: an experimental study in the dog. Surgery. 1972 Sep;72(3):414–419. [PubMed] [Google Scholar]
  8. Lautt W. W. Autoregulation of superior mesenteric artery is blocked by adenosine antagonism. Can J Physiol Pharmacol. 1986 Oct;64(10):1291–1295. doi: 10.1139/y86-218. [DOI] [PubMed] [Google Scholar]
  9. Lautt W. W., Legare D. J., Daniels T. R. The comparative effect of administration of substances via the hepatic artery or portal vein on hepatic arterial resistance, liver blood volume and hepatic extraction in cats. Hepatology. 1984 Sep-Oct;4(5):927–932. doi: 10.1002/hep.1840040524. [DOI] [PubMed] [Google Scholar]
  10. Lautt W. W., Legare D. J. The use of 8-phenyltheophylline as a competitive antagonist of adenosine and an inhibitor of the intrinsic regulatory mechanism of the hepatic artery. Can J Physiol Pharmacol. 1985 Jun;63(6):717–722. doi: 10.1139/y85-117. [DOI] [PubMed] [Google Scholar]
  11. Lautt W. W., Legare D. J., d'Almeida M. S. Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol. 1985 Mar;248(3 Pt 2):H331–H338. doi: 10.1152/ajpheart.1985.248.3.H331. [DOI] [PubMed] [Google Scholar]
  12. Lautt W. W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol. 1985 Nov;249(5 Pt 1):G549–G556. doi: 10.1152/ajpgi.1985.249.5.G549. [DOI] [PubMed] [Google Scholar]
  13. Lautt W. W. Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response. Fed Proc. 1983 Apr;42(6):1662–1666. [PubMed] [Google Scholar]
  14. Leung E., Johnston C. I., Woodcock E. A. An investigation of the receptors involved in the coronary vasodilatory effect of adenosine analogues. Clin Exp Pharmacol Physiol. 1985 Sep-Oct;12(5):515–519. doi: 10.1111/j.1440-1681.1985.tb00902.x. [DOI] [PubMed] [Google Scholar]
  15. Mathie R. T., Blumgart L. H. Haemodynamic and metabolic consequences of reversed portal venous blood flow after side-to-side portacaval shunt in the dog. Acta Chir Scand. 1987 Nov-Dec;153(11-12):653–658. [PubMed] [Google Scholar]
  16. Mathie R. T., Blumgart L. H. The hepatic haemodynamic response to acute portal venous blood flow reductions in the dog. Pflugers Arch. 1983 Nov;399(3):223–227. doi: 10.1007/BF00656719. [DOI] [PubMed] [Google Scholar]
  17. Mathie R. T., Lam P. H., Harper A. M., Blumgart L. H. The hepatic arterial blood flow response to portal vein occlusion in the dog: the effect of hepatic denervation. Pflugers Arch. 1980 Jul;386(1):77–83. doi: 10.1007/BF00584191. [DOI] [PubMed] [Google Scholar]
  18. Phillis J. W., Preston G., DeLong R. E. Effects of anoxia on cerebral blood flow in the rat brain: evidence for a role of adenosine in autoregulation. J Cereb Blood Flow Metab. 1984 Dec;4(4):586–592. doi: 10.1038/jcbfm.1984.83. [DOI] [PubMed] [Google Scholar]
  19. Randall J. R., Jones C. E. Adenosine antagonist aminophylline attenuates pacing-induced coronary functional hyperemia. Am J Physiol. 1985 Jan;248(1 Pt 2):H1–H7. doi: 10.1152/ajpheart.1985.248.1.H1. [DOI] [PubMed] [Google Scholar]
  20. Smellie F. W., Davis C. W., Daly J. W., Wells J. N. Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity. Life Sci. 1979 Jun 25;24(26):2475–2482. doi: 10.1016/0024-3205(79)90458-2. [DOI] [PubMed] [Google Scholar]
  21. Williams M. Purine receptors in mammalian tissues: pharmacology and functional significance. Annu Rev Pharmacol Toxicol. 1987;27:315–345. doi: 10.1146/annurev.pa.27.040187.001531. [DOI] [PubMed] [Google Scholar]
  22. Winn H. R., Morii S., Berne R. M. The role of adenosine in autoregulation of cerebral blood flow. Ann Biomed Eng. 1985;13(3-4):321–328. doi: 10.1007/BF02584250. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES